Probably the most critical form of mesothelioma is the malignant form. Known as malignant mesothelioma, the main causal factor is asbestos infection. According to the US National Cancer Start, "Malignant mesothelioma is a disease in which cancer (malignant) cells are present in the sac lining the chest (the pleura), the lining of the abdominal cavity (the peritoneum) or the liner around the heart (the pericardium). "
Mesothelioma can be classified into 3 types - pleural mesothelioma, peritoneal mesothelioma and pericardial mesothelioma. Pleural mesothelioma describes a cancer of the lining of the lung (pleura), peritoneal mesothelioma describes a cancer of the abdominal cavity (peritoneum) lining, and pericardial mesothelioma is really a cancer that occurs in the lining that surrounds the heart (pericardium). The actual subtypes of mesothelioma are of three basic types, one very aggressive, 1 least aggressive, and one lying between the two extremes.
Malignant mesothelioma could be diagnosed through several imaging techniques. These imaging techniques enable physicians to evaluate mesothelioma. Once mesothelioma is suspected, patients are advised to undergo several assessments, like X-ray, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) scans, as well as Positron Emission Tomography (PET) imaging. The physician may also like to take on special mesothelioma tests like thoracoscopy, peritoneoscopy and biopsy.
Learning about the stage of mesothelioma is a critical factor that helps physicians to decide your skin therapy plan. If the cancer is confined to the pleura, mesothelioma is considered local. If the cancer spreads beyond the pleura and to other parts of the body like the lungs, abdominal cavity, lymph nodes and the chest wall, mesothelioma is regarded as in an advanced stage.
The oft used and the oldest system for determining the stages of mesothelioma may be the Butchart System. The Butchart System is based on the extent of the main tumor mass available in a patient. This system divides mesothelioma into 4 stages. The TNM system, a slightly advanced system over the Butchart Program, determines staging through variables of tumor in mass and the spread, the actual lymph node involvement and metastasis. However, the latest system is known since the Brigham System, where staging is done as per the respectability and lymph node participation. In spite of such modern techniques, a definitive diagnosis of mesothelioma nevertheless remains possible through fluid diagnosis and tissue biopsy.
Mesothelioma can be classified into 3 types - pleural mesothelioma, peritoneal mesothelioma and pericardial mesothelioma. Pleural mesothelioma describes a cancer of the lining of the lung (pleura), peritoneal mesothelioma describes a cancer of the abdominal cavity (peritoneum) lining, and pericardial mesothelioma is really a cancer that occurs in the lining that surrounds the heart (pericardium). The actual subtypes of mesothelioma are of three basic types, one very aggressive, 1 least aggressive, and one lying between the two extremes.
Malignant mesothelioma could be diagnosed through several imaging techniques. These imaging techniques enable physicians to evaluate mesothelioma. Once mesothelioma is suspected, patients are advised to undergo several assessments, like X-ray, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) scans, as well as Positron Emission Tomography (PET) imaging. The physician may also like to take on special mesothelioma tests like thoracoscopy, peritoneoscopy and biopsy.
Learning about the stage of mesothelioma is a critical factor that helps physicians to decide your skin therapy plan. If the cancer is confined to the pleura, mesothelioma is considered local. If the cancer spreads beyond the pleura and to other parts of the body like the lungs, abdominal cavity, lymph nodes and the chest wall, mesothelioma is regarded as in an advanced stage.
The oft used and the oldest system for determining the stages of mesothelioma may be the Butchart System. The Butchart System is based on the extent of the main tumor mass available in a patient. This system divides mesothelioma into 4 stages. The TNM system, a slightly advanced system over the Butchart Program, determines staging through variables of tumor in mass and the spread, the actual lymph node involvement and metastasis. However, the latest system is known since the Brigham System, where staging is done as per the respectability and lymph node participation. In spite of such modern techniques, a definitive diagnosis of mesothelioma nevertheless remains possible through fluid diagnosis and tissue biopsy.
